Proteon Therapeutics Inc (PRTO) - Financial and Strategic SWOT Analysis Review

  • ID: 4278520
  • SWOT Analysis
  • 41 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Aplagon Oy
  • Bioconnect Systems Inc
  • CreatiVasc Medical LLC
  • Phraxis, Inc.
  • Stent Tek Ltd
  • Symic Biomedical Inc
  • MORE
Proteon Therapeutics Inc (PRTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Proteon Therapeutics Inc (Proteon Therapeutics) is a late-stage biopharmaceutical company that develops pharmaceutical products for the treatment of renal and vascular diseases. The company develops investigational therapies to treat hemodialysis and peripheral artery disease patients. Its product candidate includes vonapanitase, an investigational drug intended to treat vessel injury that leads to blood vessel blockage and reduced blood flow. Proteon Therapeutics’ vonapanitase is under Phase 3 clinical study in hemodialysis vascular access. The company’s product is also studied in patients with peripheral arterial disease. It owns and operates research facilities in Kansas City, Missouri. Proteon Therapeutics is headquartered in Waltham, Massachusetts, the US.

Proteon Therapeutics Inc Key Recent Developments

Nov 07, 2017: Proteon Therapeutics Announces Third Quarter 2017 Financial Results
Aug 07, 2017: Proteon Therapeutics Announces Second Quarter 2017 Financial Results
May 10, 2017: Proteon Therapeutics Announces First Quarter 2017 Financial Results
May 10, 2017: Proteon Therapeutics Q1 net loss decreases
Mar 16, 2017: Proteon Therapeutics annual net loss increases

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aplagon Oy
  • Bioconnect Systems Inc
  • CreatiVasc Medical LLC
  • Phraxis, Inc.
  • Stent Tek Ltd
  • Symic Biomedical Inc
  • MORE
Section 1 - About the Company
  • Proteon Therapeutics Inc - Key Facts
  • Proteon Therapeutics Inc - Key Employees
  • Proteon Therapeutics Inc - Key Employee Biographies
  • Proteon Therapeutics Inc - Major Products and Services
  • Proteon Therapeutics Inc - History
  • Proteon Therapeutics Inc - Company Statement
  • Proteon Therapeutics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Proteon Therapeutics Inc - Business Description
  • Proteon Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Proteon Therapeutics Inc - Strengths
  • Proteon Therapeutics Inc - Weaknesses
  • Proteon Therapeutics Inc - Opportunities
  • Proteon Therapeutics Inc - Threats
  • Proteon Therapeutics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Proteon Therapeutics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Nov 07, 2017: Proteon Therapeutics Announces Third Quarter 2017 Financial Results
  • Aug 07, 2017: Proteon Therapeutics Announces Second Quarter 2017 Financial Results
  • May 10, 2017: Proteon Therapeutics Announces First Quarter 2017 Financial Results
  • May 10, 2017: Proteon Therapeutics Q1 net loss decreases
  • Mar 16, 2017: Proteon Therapeutics annual net loss increases
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Proteon Therapeutics Inc, Key Facts
  • Proteon Therapeutics Inc, Key Employees
  • Proteon Therapeutics Inc, Key Employee Biographies
  • Proteon Therapeutics Inc, Major Products and Services
  • Proteon Therapeutics Inc, History
  • Proteon Therapeutics Inc, Subsidiaries
  • Proteon Therapeutics Inc, Key Competitors
  • Proteon Therapeutics Inc, Ratios based on current share price
  • Proteon Therapeutics Inc, Annual Ratios
  • Proteon Therapeutics Inc, Annual Ratios
  • Proteon Therapeutics Inc, Interim Ratios
  • Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Proteon Therapeutics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Proteon Therapeutics Inc, Performance Chart (2012 - 2016)
  • Proteon Therapeutics Inc, Ratio Charts
  • Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Proteon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Vascular Therapies Inc
  • Aplagon Oy
  • Bioconnect Systems Inc
  • CreatiVasc Medical LLC
  • Enceladus Pharmaceuticals BV
  • Laminate Medical Technologies Ltd.
  • Phraxis, Inc.
  • Stent Tek Ltd
  • Symic Biomedical Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll